 |
MorphoSys AG
MOR
|
1.28 |
- |
2.43 % |
$ 254 M |
Germany |
 |
ARCA biopharma
ABIO
|
1.27 |
- |
1052.0 % |
$ 415 M |
USA |
 |
Processa Pharmaceuticals
PCSA
|
0.742 |
$ 2.3 |
-1.29 % |
$ 3.01 M |
USA |
 |
Aeterna Zentaris
AEZS
|
0.781 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Albireo Pharma
ALBO
|
3.06 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Aileron Therapeutics
ALRN
|
0.702 |
- |
10.36 % |
$ 9.8 M |
USA |
 |
I-Mab
IMAB
|
1.12 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
596 |
- |
2.54 % |
$ 160 B |
France |
 |
Biophytis SA
BPTS
|
15.7 |
- |
-13.47 % |
$ 169 M |
France |
 |
Ascendis Pharma A/S
ASND
|
8.34 |
$ 220.9 |
2.49 % |
$ 5 B |
Danmark |
 |
Aptinyx
APTX
|
0.248 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Midatech Pharma plc
MTP
|
7.56 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.58 |
$ 19.57 |
1.77 % |
$ 915 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 |
- |
- |
$ 26.5 M |
USA |
 |
Phathom Pharmaceuticals
PHAT
|
-2.25 |
$ 10.47 |
4.08 % |
$ 763 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 |
- |
- |
$ 7.46 M |
Israel |
 |
AgeX Therapeutics
AGE
|
0.00262 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Acorda Therapeutics
ACOR
|
0.154 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Atreca
BCEL
|
0.625 |
- |
-11.76 % |
$ 5.79 M |
USA |
 |
Acasti Pharma
ACST
|
0.612 |
- |
4.01 % |
$ 150 M |
Canada |
 |
BeiGene, Ltd.
BGNE
|
75.9 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
bluebird bio
BLUE
|
0.344 |
- |
- |
$ 546 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 |
- |
- |
- |
Russia |
 |
Cara Therapeutics
CARA
|
0.949 |
- |
-3.03 % |
$ 260 M |
USA |
 |
Adverum Biotechnologies
ADVM
|
1.08 |
- |
- |
$ 86.2 M |
USA |
 |
Acer Therapeutics
ACER
|
-0.724 |
- |
2.71 % |
$ 14 M |
USA |
 |
Advaxis
ADXS
|
0.113 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Pliant Therapeutics
PLRX
|
0.45 |
$ 1.31 |
2.34 % |
$ 80.4 M |
USA |
 |
PMV Pharmaceuticals
PMVP
|
0.818 |
$ 1.37 |
-1.44 % |
$ 72 M |
USA |
 |
Avenue Therapeutics
ATXI
|
0.293 |
- |
-52.27 % |
$ 4.45 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
0.991 |
$ 1.33 |
0.76 % |
$ 339 M |
Britain |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
0.862 |
$ 8.31 |
1.59 % |
$ 111 M |
USA |
 |
CRISPR Therapeutics AG
CRSP
|
2.28 |
$ 47.09 |
1.42 % |
$ 4.23 B |
Schweiz |
 |
Cyclacel Pharmaceuticals
CYCC
|
-2.57 |
- |
-5.98 % |
$ 34.1 M |
USA |
 |
ChemoCentryx
CCXI
|
0.00635 |
- |
- |
$ 3.74 B |
USA |
 |
Prelude Therapeutics Incorporated
PRLD
|
4.04 |
$ 3.26 |
4.49 % |
$ 251 M |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.9 |
- |
- |
$ 2.02 B |
USA |
 |
ProQR Therapeutics N.V.
PRQR
|
0.607 |
$ 1.58 |
6.04 % |
$ 99.5 M |
Niderland |
 |
BioDelivery Sciences International
BDSI
|
1.64 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Enochian Biosciences
ENOB
|
-5.41 |
- |
- |
$ 40.5 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 |
- |
- |
$ 1.01 B |
USA |
 |
CureVac N.V.
CVAC
|
5.13 |
- |
- |
$ 867 M |
Germany |
 |
Palatin Technologies
PTN
|
-0.0175 |
$ 21.0 |
5.79 % |
$ 19.5 M |
USA |
 |
Bellerophon Therapeutics
BLPH
|
31 |
- |
-74.18 % |
$ 955 K |
USA |
 |
Akero Therapeutics
AKRO
|
4.34 |
- |
- |
$ 3.67 B |
USA |
 |
Pulmatrix
PULM
|
2.85 |
$ 2.12 |
-1.4 % |
$ 7.74 M |
USA |
 |
Arbutus Biopharma Corporation
ABUS
|
11.1 |
$ 4.53 |
5.1 % |
$ 868 M |
Canada |
 |
Homology Medicines
FIXX
|
0.429 |
- |
0.77 % |
$ 53.4 M |
USA |